Skip to main content
. 2017 Nov 10;2017(11):CD011767. doi: 10.1002/14651858.CD011767.pub2

NCT01472523.

Trial name or title A safer pre‐natal diagnosis using free DNA in maternal blood (IONA®).
Target condition and reference standard(s) Target conditions: T21, T18, T13 and other chromosomal abnormalities yet to be determined.
Reference standards: prenatal karyotype and follow‐up for 1 year.
Index and comparator tests gNIPT by TMPS (selective amplification of fetal DNA) by Premaitha Health.
Starting date April 2007.
Contact information Brenda Kelly
National Health Service, United Kingdom
Aim to study To validate a novel gNIPT method that could increase the titre of fetal DNA within a given sample.
Funding source or sponsor of the study Study funded by Premaitha Health.
Information about the authors contacted No need for further contact.
Notes